Related Experiment Videos

Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase

R Miesel1, M Kurpisz, H Kröger

  • 1Department of Biochemistry, Deutsches RheumaForschungsZentrum, Berlin, Germany.

Inflammation
|June 1, 1995
PubMed

Insights

Nicotinamide, a poly(ADPR) polymerase (PARP) inhibitor, suppressed arthritis by 35% in mice. This suggests inhibiting PARP and NADPH oxidase may treat arthritis by reducing oxidative stress.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Poly(ADPR) polymerase (PARP) is a nuclear enzyme activated by DNA strand breaks.
  • PARP activation contributes to apoptosis by depleting cellular NAD and ATP.
  • Oxidative stress is implicated in the pathogenesis of inflammatory diseases like arthritis.

Purpose of the Study:

  • To investigate the role of oxidative stress-dependent PARP activation in arthritis.
  • To evaluate the antiarthritic effects of nicotinamide (NA), a biogenic PARP inhibitor.

Main Methods:

  • Potassium peroxochromate-induced arthritis model in DBA/1 x B10A(4R) mice.
  • Administration of daily doses of nicotinamide (4 mmol/kg).
  • Measurement of reactive oxygen species (ROS) generation and NADPH oxidase activity in phagocytes.

Main Results:

  • Nicotinamide suppressed arthritis by 35% and inhibited ROS generation.
  • Arthritis onset, progression, and remission correlated with neutrophil and monocyte respiratory burst.
  • A dose-dependent inhibition of NADPH oxidase activity was observed in human phagocytes.

Conclusions:

  • Oxidative stress-induced alterations in cellular signaling pathways are crucial in arthritis development.
  • Simultaneous inhibition of PARP and NADPH oxidase shows potential for suppressing arthritis.

Related Concept Videos